🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/03/2012 | 36,86 | 37,15 | 36,48 | 36,56 | -1,26% | 1,81% | 17.066.470 |
| 27/03/2012 | 36,98 | 37,21 | 36,91 | 37,02 | +0,36% | 0,83% | 13.298.596 |
| 26/03/2012 | 36,51 | 36,93 | 36,40 | 36,89 | +1,71% | 1,44% | 12.576.734 |
| 23/03/2012 | 35,97 | 36,31 | 35,89 | 36,27 | +1,09% | 1,17% | 11.283.292 |
| 22/03/2012 | 35,82 | 36,19 | 35,81 | 35,88 | -0,27% | 1,07% | 13.615.092 |
| 21/03/2012 | 36,15 | 36,15 | 35,91 | 35,97 | -0,16% | 0,66% | 12.048.856 |
| 20/03/2012 | 35,93 | 36,18 | 35,90 | 36,03 | -0,34% | 0,80% | 14.515.848 |
| 19/03/2012 | 36,20 | 36,30 | 36,11 | 36,15 | -0,37% | 0,53% | 10.215.275 |
| 16/03/2012 | 36,42 | 36,57 | 36,23 | 36,29 | -0,08% | 0,94% | 19.446.164 |
| 15/03/2012 | 36,40 | 36,50 | 36,21 | 36,32 | -0,42% | 0,79% | 12.833.808 |
| 14/03/2012 | 36,63 | 36,64 | 36,35 | 36,47 | -0,16% | 0,81% | 12.322.384 |
| 13/03/2012 | 36,14 | 36,55 | 35,97 | 36,53 | +0,47% | 1,58% | 15.722.725 |
| 12/03/2012 | 35,99 | 36,36 | 35,93 | 36,36 | +1,33% | 1,22% | 11.395.323 |
| 09/03/2012 | 35,76 | 36,16 | 35,74 | 35,88 | +0,53% | 1,17% | 46.658.008 |
| 08/03/2012 | 35,90 | 36,08 | 35,64 | 35,69 | +0,24% | 1,22% | 42.886.256 |
| 07/03/2012 | 35,62 | 35,72 | 35,22 | 35,60 | -0,35% | 1,39% | 17.679.760 |
| 06/03/2012 | 36,24 | 36,62 | 35,59 | 35,73 | -2,63% | 2,84% | 19.487.874 |
| 05/03/2012 | 36,27 | 36,76 | 36,25 | 36,69 | +1,37% | 1,39% | 19.558.929 |
| 02/03/2012 | 35,90 | 36,35 | 35,84 | 36,19 | +0,37% | 1,41% | 13.676.819 |
| 01/03/2012 | 36,40 | 36,41 | 35,94 | 36,06 | -1,00% | 1,31% | 18.920.068 |
| 29/02/2012 | 36,71 | 36,73 | 36,37 | 36,42 | -0,55% | 0,96% | 15.971.520 |
| 28/02/2012 | 36,40 | 36,73 | 36,26 | 36,62 | +0,60% | 1,28% | 9.916.071 |
| 27/02/2012 | 36,20 | 36,51 | 36,10 | 36,40 | -0,13% | 1,13% | 17.304.052 |
| 24/02/2012 | 36,73 | 36,74 | 36,39 | 36,45 | -0,80% | 0,94% | 8.896.996 |
| 23/02/2012 | 36,36 | 36,76 | 36,36 | 36,75 | +0,76% | 1,10% | 10.823.954 |
| 22/02/2012 | 36,32 | 36,48 | 36,16 | 36,47 | +0,24% | 0,87% | 10.304.984 |
| 21/02/2012 | 36,71 | 36,86 | 36,34 | 36,38 | -1,12% | 1,43% | 11.373.106 |
| 17/02/2012 | 36,85 | 37,10 | 36,56 | 36,79 | +1,10% | 1,45% | 18.826.586 |
| 16/02/2012 | 36,34 | 36,40 | 36,07 | 36,39 | +0,32% | 0,92% | 10.933.574 |
| 15/02/2012 | 36,51 | 36,53 | 36,15 | 36,28 | -0,50% | 1,02% | 12.769.670 |